WASHINGTON (AP) - The Food and Drug Administration says it has approved a first-of-a-kind heart-zapping implant from Boston Scientific that that does not directly touch the heart.
Implantable defibrillators use thin wires to send electrical signals that disrupt dangerous heart rhythms. Surgeons have traditionally connected the wires to the heart through a blood vessel in the upper chest.
The new device from Boston Scientific uses wires that sit just below the skin's surface and do not need to be threaded through the heart's blood vessels.
Natick, Mass.-based Boston Scientific Corp. acquired the device through a $150 million buyout of San Clemente, Calif.-based Cameron Health. Under the terms of the deal, Boston Scientific will pay an additional $150 million for FDA approval, plus up to $1 billion in payments based on future sales figures.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
A man who was wrongly convicted of second degree murder in 2009 has been set free after spending four years in prison.
Investigators are trying to determine who dumped a dog on the side of the road inside a zipped up Coors Light thermal bag.
A man once featured on the Cattaraugus County Top 10 Most Wanted List has pleaded guilty after being extradited from Indiana.
Lake effect snow warning in effect for southern tier.
Two men have been arrested by Wyoming County Sheriff's deputies and charged with selling heroin in the Village of Attica.
A woman was arrested Sunday after she allegedly tried to bite her neighbor during an argument over offensive odors.